Patents by Inventor Joyoti DEY

Joyoti DEY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF CANCER
    Publication number: 20220023261
    Abstract: The disclosure herein provides combination therapies for the treatment of cancers such as Leukemia, lymphoma and triple negative breast cancer. The disclosure provides combination therapies of CDK inhibitors, e.g., a CDK inhibitor represented by Formula I: or a pharmaceutically acceptable salt thereof together with a BCL-2 inhibitor or proteasome inhibitor for the treatment of cancer.
    Type: Application
    Filed: July 9, 2021
    Publication date: January 27, 2022
    Applicant: Presage Biosciences, Inc.
    Inventors: Richard KLINGHOFFER, Joyoti DEY
  • PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF CANCER
    Publication number: 20210283104
    Abstract: The disclosure herein provides combination therapies for the treatment of cancers such as Leukemia, lymphoma and triple negative breast cancer. The disclosure provides combination therapies of CDK inhibitors, e.g., a CDK inhibitor represented by Formula (I): or a pharmaceutically acceptable salt thereof together with a BCL-2 inhibitor or proteasome inhibitor for the treatment of cancer.
    Type: Application
    Filed: June 3, 2021
    Publication date: September 16, 2021
    Applicant: Presage Biosciences, Inc.
    Inventors: Richard KLINGHOFFER, Joyoti DEY
  • PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF CANCER
    Publication number: 20200383948
    Abstract: The disclosure herein provides combination therapies for the treatment of cancers such as Leukemia, lymphoma and triple negative breast cancer. The disclosure provides combination therapies of CDK inhibitors, e.g., a CDK inhibitor represented by Formula (I): or a pharmaceutically acceptable salt thereof together with a BCL-2 inhibitor or proteasome inhibitor for the treatment of cancer.
    Type: Application
    Filed: March 28, 2017
    Publication date: December 10, 2020
    Applicant: Presage Biosciences, Inc.
    Inventors: Richard KLINGHOFFER, Joyoti DEY
  • PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF CANCER
    Publication number: 20190275004
    Abstract: The disclosure herein provides combination therapies for the treatment of cancers such as Leukemia, lymphoma and triple negative breast cancer. The disclosure provides combination therapies of CDK inhibitors, e.g., a CDK inhibitor represented by Formula (I): or a pharmaceutically acceptable salt thereof together with a BCL-2 inhibitor or proteasome inhibitor for the treatment of cancer.
    Type: Application
    Filed: May 28, 2019
    Publication date: September 12, 2019
    Applicant: Presage Biosciences, Inc.
    Inventors: Richard KLINGHOFFER, Joyoti DEY